Clinical Trials Browser

Phase 2 × Lymphoma, Extranodal NK-T-Cell × Bevacizumab × Clear all

NCT01921790 2013-08-22

Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma

Phase 2 Unknown

Lymphoma, Extranodal NK-T-Cell